Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2013-06-30
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vitamin D for Cognition in Bipolar Disorder
NCT05357859
Can Vitamin D3 Supplementation Affect Treatment Outcomes in Patients With Depression
NCT01390662
Vitamin D Supplementation in Patients With Depression
NCT03766074
Vitamin D for Improving Metabolic Control and Depressive Symptoms
NCT01185574
Effects of Vitamin D Supplementation on Depression and Inflammatory Markers
NCT04898725
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Vitamin D3
Vitamin D3, Cholecalciferol, 5000IU po qday for 12 weeks
Vitamin D3, Cholecalciferol
Placebo
methylcellulose po qday for 12weeks
Placebo
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D3, Cholecalciferol
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Bipolar disorder (I,II or NOS),
* MADRS Score\>7 (mild),
* 25(OH)D level \<30ng/ml (insufficient).
* able to take the prescribed vitamin D by mouth
Exclusion Criteria
* liver and kidney diseases,
* known parathyroid disorder,
* disorders of vitamin D metabolism,
* taking vitamin D replacement therapy,
* fat digestion disorder,
* diabetes mellitus,
* gi surgery
* If the serum calcium in the range 2.50-2.55 mmol L, inclusion required a serum PTH below 5.0 pmol L-acute psychiatric urgency:
* active suicidality,
* acute psychosis,
* active substance use\<6mo or
* pregnant or nursing females
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Massachusetts, Worcester
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wendy Marsh
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Wendy Marsh, MD MSc
Role: PRINCIPAL_INVESTIGATOR
University of Massachusetts, Worcester
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Massachusettes
Worcester, Massachusetts, United States
University of Massachusetts School of Medicine
Worcester, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NARSADYI13-15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.